LTBK-02. Safety of growth hormone replacement therapy in childhood craniopharyngioma

Introduction: Treatment for childhood-onset craniopharyngioma (cCP) has shifted from complete to limited resection aiming to avoid additional hypothalamic morbidity. Up to 90% of cCP patients develop growth hormone deficiency (GHD). GH replacement therapy (GHRT) is of high importance for linear grow...

Descripción completa

Detalles Bibliográficos
Autores principales: van Schaik, Jiska, Kormelink, Eline, Schouten-van Meeteren, Netteke, de Vos-Kerkhof, Evelien, Bakker, Boudewijn, Fiocco, Marta, Hoving, Eelco, Tissing, Wim, van Santen, Hanneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Late Breaking Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189949/
http://dx.doi.org/10.1093/neuonc/noac079.714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189949/
http://dx.doi.org/10.1093/neuonc/noac079.714

Ejemplares similares